Camille Petitfils
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Camille Petitfils has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Patrice D. Cani
Louvain Drug Research Institute (LDRI), Metabolism and Nutrition Research Group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium
3 shared publications Anthony Puel
Metabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de Louvain
2 shared publications- Matthias Van Hul
Louvain Drug Research Institute (LDRI), Metabolism and Nutrition Research Group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium
2 shared publications - Nathalie M. Delzenne
UCLouvain, Louvain Drug Research Institute, LDRI, Metabolism and Nutrition Research Group, MNut, Brussels, Belgium
2 shared publications - Nicolas Cenac
Toulouse University 3 Paul Sabatier, Toulouse, France
2 shared publications Alexandre Guy
Institut des Biomolécules Max Mousseron IBMM, UMR 5247 CNRS, Université de Montpellier-ENSCM, Montpellier, France
1 shared publication
Latest Publications
- 6 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Identification et caractérisation de métabolites lipidiques bactériens impliqués dans l'homéostasie intestinale
Par sa contribution à l'ensemble des grandes fonctions de l'organisme, le microbiote intestinal possède un rôle essentiel dans la physiologie et la pathologie de son hôte. Un microbiote est caractérisé par son répertoire de gènes exprimés et, plus important encore, par les métabolites qu'il sécrète. De nombreuses études ont déterminé la composition taxonomique du microbiote, mais peu en ont caractérisé les gènes actifs, les protéines ou les métabolites, ce qui pourrait être plus pertinent. En effet, la composition taxonomique du microbiote humain varie énormément d'un individu à l'autre, tandis que sa composition génétique ou sa capacité fonctionnelle est très conservée. La capacité fonctionnelle du microbiote est redondante et capitale pour maintenir sa stabilité et sa résilience. A la notion de redondance fonctionnelle est associée l'idée que, jusqu'à un certain point, les espèces sont substituables d'un microbiote à l'autre en termes de fonctionnalité. Il est donc majeur d'identifier les métabolites du microbiote intestinal et de déterminer leur effet sur l'hôte. Les travaux présentés dans cette thèse sont focalisés sur la caractérisation de métabolites lipidiques produits par les bactéries intestinales afin d'étudier les interactions entre le microbiote intestinal et son hôte. Pour notre premier projet, nous nous sommes intéressés à une souche d'Escherichia coli, E. coli Nissle 1917 (EcN), indiquée comme probiotique dans les phases de rémission de la rectocolite hémorragique. Nous avons quantifié une augmentation de la concentration d'un acide gras ß-hydroxylé, le C18-3OH, produit par EcN par rapport à des E. coli commensales ou pathogènes. Nous avons donc testé les propriétés anti-inflammatoires de ce lipide dans un modèle murin de colite induit par le DSS. Le C18-3OH diminuait la sévérité de l'inflammation en se liant au récepteur nucléaire PPARgamma. L'utilisation d'un prébiotique (fructo-oligosaccharide) ayant une activité anti-inflammatoire, nous a permis de démontrer qu'une autre bactérie du microbiote intestinal, Holdemanella biformis, était également capable de produire de grande quantité de C18-3OH. Le microbiote joue un rôle critique dans la maturation et le développement, notamment intestinal, de son hôte. Par exemple, chez la souris, une modification du microbiote, ou dysbiose, induite par des antibiotiques lors du sevrage augmente l'intensité de l'inflammation dans un modèle de colite. Le microbiote étant extrêmement sensible à son environnement, le stress, qu'il soit subit en prénatal, post natal ou à l'âge adulte, modifie sa composition. Néanmoins, le lien de causalité entre le stress prénatal, la dysbiose du microbiote intestinal et les troubles fonctionnels digestifs n'a jamais été établi. Dans un modèle murin de stress prénatal (SP), nous avons montré que la descendance adulte mâle et femelle développait une hypersensibilité viscérale associée à une dysbiose du microbiote intestinal et une absence d'inflammation macroscopique, trois caractéristiques du syndrome de l'intestin irritable. Comme l'abondance de Ligilactobacillus murinus/animalis était inversement corrélée à l'hypersensibilité viscérale, nous avons étudié les lipides produits par cette bactérie et identifié un lipopeptide, le C14AsnGABA. L'administration intra-colique de cette molécule restaurait une normo-sensibilité viscérale chez les souris SP. Ces deux projets nous ont permis d'identifier des lipides ayant des propriétés anti- inflammatoires ou analgésiques produits par des bactéries présentes dans le microbiote intestinal. Ces molécules pourraient jouer un rôle dans l'interaction entre le microbiote et son hôte.
- 6 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Identification et caractérisation de métabolites lipidiques bactériens impliqués dans l'homéostasie intestinale
Par sa contribution à l'ensemble des grandes fonctions de l'organisme, le microbiote intestinal possède un rôle essentiel dans la physiologie et la pathologie de son hôte. Un microbiote est caractérisé par son répertoire de gènes exprimés et, plus important encore, par les métabolites qu'il sécrète. De nombreuses études ont déterminé la composition taxonomique du microbiote, mais peu en ont caractérisé les gènes actifs, les protéines ou les métabolites, ce qui pourrait être plus pertinent. En effet, la composition taxonomique du microbiote humain varie énormément d'un individu à l'autre, tandis que sa composition génétique ou sa capacité fonctionnelle est très conservée. La capacité fonctionnelle du microbiote est redondante et capitale pour maintenir sa stabilité et sa résilience. A la notion de redondance fonctionnelle est associée l'idée que, jusqu'à un certain point, les espèces sont substituables d'un microbiote à l'autre en termes de fonctionnalité. Il est donc majeur d'identifier les métabolites du microbiote intestinal et de déterminer leur effet sur l'hôte. Les travaux présentés dans cette thèse sont focalisés sur la caractérisation de métabolites lipidiques produits par les bactéries intestinales afin d'étudier les interactions entre le microbiote intestinal et son hôte. Pour notre premier projet, nous nous sommes intéressés à une souche d'Escherichia coli, E. coli Nissle 1917 (EcN), indiquée comme probiotique dans les phases de rémission de la rectocolite hémorragique. Nous avons quantifié une augmentation de la concentration d'un acide gras ß-hydroxylé, le C18-3OH, produit par EcN par rapport à des E. coli commensales ou pathogènes. Nous avons donc testé les propriétés anti-inflammatoires de ce lipide dans un modèle murin de colite induit par le DSS. Le C18-3OH diminuait la sévérité de l'inflammation en se liant au récepteur nucléaire PPARgamma. L'utilisation d'un prébiotique (fructo-oligosaccharide) ayant une activité anti-inflammatoire, nous a permis de démontrer qu'une autre bactérie du microbiote intestinal, Holdemanella biformis, était également capable de produire de grande quantité de C18-3OH. Le microbiote joue un rôle critique dans la maturation et le développement, notamment intestinal, de son hôte. Par exemple, chez la souris, une modification du microbiote, ou dysbiose, induite par des antibiotiques lors du sevrage augmente l'intensité de l'inflammation dans un modèle de colite. Le microbiote étant extrêmement sensible à son environnement, le stress, qu'il soit subit en prénatal, post natal ou à l'âge adulte, modifie sa composition. Néanmoins, le lien de causalité entre le stress prénatal, la dysbiose du microbiote intestinal et les troubles fonctionnels digestifs n'a jamais été établi. Dans un modèle murin de stress prénatal (SP), nous avons montré que la descendance adulte mâle et femelle développait une hypersensibilité viscérale associée à une dysbiose du microbiote intestinal et une absence d'inflammation macroscopique, trois caractéristiques du syndrome de l'intestin irritable. Comme l'abondance de Ligilactobacillus murinus/animalis était inversement corrélée à l'hypersensibilité viscérale, nous avons étudié les lipides produits par cette bactérie et identifié un lipopeptide, le C14AsnGABA. L'administration intra-colique de cette molécule restaurait une normo-sensibilité viscérale chez les souris SP. Ces deux projets nous ont permis d'identifier des lipides ayant des propriétés anti- inflammatoires ou analgésiques produits par des bactéries présentes dans le microbiote intestinal. Ces molécules pourraient jouer un rôle dans l'interaction entre le microbiote et son hôte.
- Top Cited PapersOpen Access
- 9 January 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2612580
Akkermansia muciniphila modulates intestinal mucus composition to counteract high-fat diet-induced obesity in mice
This study investigates whether live Akkermansia muciniphila MucT supplementation can counteract obesity and metabolic dysfunctions induced by a high-fat diet (HFD) by modulating intestinal mucus production, secretion and composition. C57BL/6J mice were fed an HFD with or without live A. muciniphila MucT (2 × 108 CFU per day) supplementation or a control diet for 6 weeks. Body weight, fat mass gain and metabolic markers were measured. Intestinal mucus characteristics were assessed via gene expression analysis of mucins and analysed mucin glycosylation by tandem mass spectrometry (MS/MS). Mice receiving live A. muciniphila MucT exhibited reduced body weight gain and fat mass accumulation compared to HFD controls, without changes in muscle mass. A. muciniphila improved gut barrier integrity by increasing antimicrobial peptide expression in the jejunum and in the colon of HFD-fed mice. Furthermore, live A. muciniphila MucT influenced markers of goblet cell differentiation and restored the expression of mucin markers altered by HFD. Specifically, live A. muciniphila MucT counteracted HFD-induced mucin 3 (Muc3) expression depletion in the colon. Although the overall mucus thickness was not affected by live A. muciniphila MucT, the bacteria significantly modulated mucin glycans composition. Live A. muciniphila MucT did not change the gut microbiota composition. These findings highlight the protective effects of live A. muciniphila MucT against diet-induced metabolic dysfunctions by modulating adiposity, mucus layer composition, and glycan profiles. This reinforces its potential as a therapeutic strategy for metabolic disorders associated with gut microbiota alterations.
- 9 January 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2612580
Top Cited PapersOpen AccessAkkermansia muciniphila modulates intestinal mucus composition to counteract high-fat diet-induced obesity in mice
This study investigates whether live Akkermansia muciniphila MucT supplementation can counteract obesity and metabolic dysfunctions induced by a high-fat diet (HFD) by modulating intestinal mucus production, secretion and composition. C57BL/6J mice were fed an HFD with or without live A. muciniphila MucT (2 × 108 CFU per day) supplementation or a control diet for 6 weeks. Body weight, fat mass gain and metabolic markers were measured. Intestinal mucus characteristics were assessed via gene expression analysis of mucins and analysed mucin glycosylation by tandem mass spectrometry (MS/MS). Mice receiving live A. muciniphila MucT exhibited reduced body weight gain and fat mass accumulation compared to HFD controls, without changes in muscle mass. A. muciniphila improved gut barrier integrity by increasing antimicrobial peptide expression in the jejunum and in the colon of HFD-fed mice. Furthermore, live A. muciniphila MucT influenced markers of goblet cell differentiation and restored the expression of mucin markers altered by HFD. Specifically, live A. muciniphila MucT counteracted HFD-induced mucin 3 (Muc3) expression depletion in the colon. Although the overall mucus thickness was not affected by live A. muciniphila MucT, the bacteria significantly modulated mucin glycans composition. Live A. muciniphila MucT did not change the gut microbiota composition. These findings highlight the protective effects of live A. muciniphila MucT against diet-induced metabolic dysfunctions by modulating adiposity, mucus layer composition, and glycan profiles. This reinforces its potential as a therapeutic strategy for metabolic disorders associated with gut microbiota alterations.
- Open Access
- 27 August 2025
- Published by Springer Nature in Nature
- Vol. 646 (8083) , 161-170
Maternal stress triggers early-life eczema through fetal mast cell programming
Prenatal stress (PS) is a repeated exposure to aversive situations during pregnancy, including high emotional strain, which is suspected to affect homeostatic systems in infants. Paediatric eczema develops quickly after birth at flexural sites subjected to continuous mechanical constraints1,2. Although epidemiological studies have suggested an association between PS and a higher risk of eczema in children3,4,5,6, no causative biological link has yet been identified. Here we show that eczema at birth originates from molecular dysregulations of neuroimmune circuits in utero, triggered by fluctuations in the maternal hypothalamic–pituitary–adrenal axis. We found that offspring of stressed pregnant dams have dysregulated mast cells and skin-projecting neurons and quickly develop eczema in response to harmless mechanical friction. We demonstrated that PS transiently modulates amniotic fluid corticosterone concentrations, which directly alters the activation program of skin mast cells expressing the glucocorticoid receptor Nr3c1 and the adjacent sensory neurons conveying mechanosensation. Therapeutic normalization of maternal corticosterone concentrations or genetic depletion of Mcpt5+ mast cells during stressed gestation prevents fetal immune dysregulation and protects against eczema development after birth. Our findings support a new model in which early-onset paediatric eczema originates from dysregulations in the fetal immune system, caused by fluctuations in maternal glucocorticoids induced by stress.
- 27 August 2025
- Published by Springer Nature in Nature
- Vol. 646 (8083) , 161-170
Open AccessMaternal stress triggers early-life eczema through fetal mast cell programming
Prenatal stress (PS) is a repeated exposure to aversive situations during pregnancy, including high emotional strain, which is suspected to affect homeostatic systems in infants. Paediatric eczema develops quickly after birth at flexural sites subjected to continuous mechanical constraints1,2. Although epidemiological studies have suggested an association between PS and a higher risk of eczema in children3,4,5,6, no causative biological link has yet been identified. Here we show that eczema at birth originates from molecular dysregulations of neuroimmune circuits in utero, triggered by fluctuations in the maternal hypothalamic–pituitary–adrenal axis. We found that offspring of stressed pregnant dams have dysregulated mast cells and skin-projecting neurons and quickly develop eczema in response to harmless mechanical friction. We demonstrated that PS transiently modulates amniotic fluid corticosterone concentrations, which directly alters the activation program of skin mast cells expressing the glucocorticoid receptor Nr3c1 and the adjacent sensory neurons conveying mechanosensation. Therapeutic normalization of maternal corticosterone concentrations or genetic depletion of Mcpt5+ mast cells during stressed gestation prevents fetal immune dysregulation and protects against eczema development after birth. Our findings support a new model in which early-onset paediatric eczema originates from dysregulations in the fetal immune system, caused by fluctuations in maternal glucocorticoids induced by stress.
- Open Access
- 3 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0320698
Gut microbiota composition differences are associated with geographic location and age in malaria-endemic regions of Rwanda
Evidence suggests that a significant interplay exists between the host gut microbiota and both the transmission and severity of malaria. Therefore, we explored the association between malaria and the gut microbiota across various geographic regions, considering host’s nutritional habits, helminth coinfections and age. This observational study was conducted in 3 malaria-endemic provinces of Rwanda: West, South and East. Demographic data, blood and fecal samples were collected from 169 participants (85 females and 84 males) aged between 2–78 years. We used questionnaire-derived qualitative data based on geographic regions, age, and nutrition. Malaria and soil-transmitted helminth diagnosis was assessed by microscopy. The gut microbial composition was analyzed based on bacterial 16S rRNA gene amplicon sequencing. We observed that preschool children had a significantly lower microbiota diversity compared to both school children (q = 0.027, K-Wallis) and adults (q = 0.011, K-Wallis). Unlike age, infection status (uninfected, malaria alone, soil-transmitted helminth alone or coinfection) was not significantly associated with the gut microbiota. However, using Bray-Curtis distances, we found a significantly differential gut microbial beta-diversity with a convergent distribution in the Western province compared to the other provinces (q = 0.0045, pairwise PERMANOVA). This geographic difference was not explained by any change in energy intake, protein, lipids, or carbohydrates consumption but was likely due to lower dietary fibre intake in the West compared to the South (q < 0.0001, ANOVA) and the East (q = 0.07, ANOVA). In conclusion, we have not found significant links between infection and gut microbiota. However, we showed a significant difference in the gut microbiota composition of people living in different geographic locations in Rwanda, possibly due to their nutritional habits.
- 3 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0320698
Open AccessGut microbiota composition differences are associated with geographic location and age in malaria-endemic regions of Rwanda
Evidence suggests that a significant interplay exists between the host gut microbiota and both the transmission and severity of malaria. Therefore, we explored the association between malaria and the gut microbiota across various geographic regions, considering host’s nutritional habits, helminth coinfections and age. This observational study was conducted in 3 malaria-endemic provinces of Rwanda: West, South and East. Demographic data, blood and fecal samples were collected from 169 participants (85 females and 84 males) aged between 2–78 years. We used questionnaire-derived qualitative data based on geographic regions, age, and nutrition. Malaria and soil-transmitted helminth diagnosis was assessed by microscopy. The gut microbial composition was analyzed based on bacterial 16S rRNA gene amplicon sequencing. We observed that preschool children had a significantly lower microbiota diversity compared to both school children (q = 0.027, K-Wallis) and adults (q = 0.011, K-Wallis). Unlike age, infection status (uninfected, malaria alone, soil-transmitted helminth alone or coinfection) was not significantly associated with the gut microbiota. However, using Bray-Curtis distances, we found a significantly differential gut microbial beta-diversity with a convergent distribution in the Western province compared to the other provinces (q = 0.0045, pairwise PERMANOVA). This geographic difference was not explained by any change in energy intake, protein, lipids, or carbohydrates consumption but was likely due to lower dietary fibre intake in the West compared to the South (q < 0.0001, ANOVA) and the East (q = 0.07, ANOVA). In conclusion, we have not found significant links between infection and gut microbiota. However, we showed a significant difference in the gut microbiota composition of people living in different geographic locations in Rwanda, possibly due to their nutritional habits.
- Open Access
Fecal Dysosmobacter spp. concentration is linked to plasma lipidome in insulin-resistant individuals with overweight, obesity and metabolic syndrome
Background: Obesity is reaching epidemic proportions worldwide. This excessive increase of adipose tissue is a risk factor for the development of multiple diseases and premature death. Amongst associated diseases, metabolic syndrome is one of the main comorbidities of obesity. In this context, the gut microbiota has been recognized as both shaping and responding to host energy metabolism. Recently metabolomics has emerged as a powerful tool to capture a snapshot of the metabolites present in a specific tissue, offering new insights into host-microbiota interactions. Integrating metabolomics with gut microbiota studies could help us better understand how specific species impact on host metabolomic profile. Dysosmobacter welbionis has been identified as a promising next generation beneficial bacteria with potential effects on fat mass and glucose metabolism in mice, and fecal Dysosmobacter spp concentration was inversely correlated to body mass index fasting glucose and plasmatic HbA1c in humans. Methods: Concentration of Dysosmobacter spp was quantified by qPCR in the stools of insulin resistant overweight/obese participants with a metabolic syndrome and plasma metabolites were analyzed using untargeted metabolomics. Correlations between Dysosmobacter spp fecal abundance and the 1169 identified plasma metabolites were uncovered using Spearman correlations followed by a false discovery rate correction. Results: Interestingly, among the detected metabolites, Dysosmobacter spp was exclusively associated with lipid molecules, primarily structural lipids involved in membrane formation. This finding aligns with previous in vivo studies highlighting lipid profile alterations in multiple tissues of mice treated with this bacterium. Conclusion: These results suggest that Dysosmobacter spp plays a specific role in host lipid metabolism. Further studies are needed to elucidate the underlying mechanisms and assess its potential therapeutic applications.
Open AccessFecal Dysosmobacter spp. concentration is linked to plasma lipidome in insulin-resistant individuals with overweight, obesity and metabolic syndrome
Background: Obesity is reaching epidemic proportions worldwide. This excessive increase of adipose tissue is a risk factor for the development of multiple diseases and premature death. Amongst associated diseases, metabolic syndrome is one of the main comorbidities of obesity. In this context, the gut microbiota has been recognized as both shaping and responding to host energy metabolism. Recently metabolomics has emerged as a powerful tool to capture a snapshot of the metabolites present in a specific tissue, offering new insights into host-microbiota interactions. Integrating metabolomics with gut microbiota studies could help us better understand how specific species impact on host metabolomic profile. Dysosmobacter welbionis has been identified as a promising next generation beneficial bacteria with potential effects on fat mass and glucose metabolism in mice, and fecal Dysosmobacter spp concentration was inversely correlated to body mass index fasting glucose and plasmatic HbA1c in humans. Methods: Concentration of Dysosmobacter spp was quantified by qPCR in the stools of insulin resistant overweight/obese participants with a metabolic syndrome and plasma metabolites were analyzed using untargeted metabolomics. Correlations between Dysosmobacter spp fecal abundance and the 1169 identified plasma metabolites were uncovered using Spearman correlations followed by a false discovery rate correction. Results: Interestingly, among the detected metabolites, Dysosmobacter spp was exclusively associated with lipid molecules, primarily structural lipids involved in membrane formation. This finding aligns with previous in vivo studies highlighting lipid profile alterations in multiple tissues of mice treated with this bacterium. Conclusion: These results suggest that Dysosmobacter spp plays a specific role in host lipid metabolism. Further studies are needed to elucidate the underlying mechanisms and assess its potential therapeutic applications.
- 1 February 2022
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1193, 339316
Discovery and quantification of lipoamino acids in bacteria
- 1 February 2022
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1193, 339316
Discovery and quantification of lipoamino acids in bacteria